Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia

Not Applicable

Recruiting

• Conditions: type 2 diabetes complicated with dyslipidemia

• Registration Number: JPRN-UMIN000006537
• Lead Sponsor: Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with hypersensitivity against ezetimibe and pravastatin, 2)Patients with severe renal dysfunction and severe hepatic dysfunction, 3)Pregnant women, women who may be pregnant, and breast-feeding women. 4)Patients with drug-induced and familial dyslipidemia, 5)Patients treated with insulin 6)Patients judged by the investigator/ sub investigator to be ineligible for some other reason.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change and percent change in TC, LDL-C, HDL-C, TG, Remnant like particle cholesterol (RLP-C), small dense LDL and FFA. Change and percent change in HbA1c and insulin